To further investigate the relationship between TC2N expression and tumor differentiation in a clinical context, we performed a retrospective analysis on our previous Tissue Microarray (TMA) cohort (Cohort 1) consisting of 272 human lung tumor tissues [9]. The gene discussed is TC2N; the disease is neoplasm.